Value

Evidence gaps for payer and HTA decision-making

Unclear or undifferentiated clinical and economic value

Difficulty translating clinical innovation into payer-relevant value

Value that is difficult to communicate to different stakeholders.

Three connected capability clusters

Evidence Strategy & Generation

HEOR, HTA & RWE

Value Demonstration & Communication

Define the evidence decision makers will require — and close the gaps early.

Quantify clinical and economic value to the standard payers and HTA bodies expect.

Translate evidence into a clear, credible value case for each stakeholder.

HEOR Strategy & Studies
HTA Strategy & Readiness
Real-World Evidence Strategy
Economic Evaluation

Value Proposition Development
Value Demonstration
Stakeholder-Specific Value Communication

Evidence Strategy
Evidence Generation
Evidence-Gap Assessment

Where Value connects

Access

Value informs every decision that follows

Payer and HTA decisions, pricing and reimbursement

Commercial Excellence

Value is the foundation for regulatory, access and commercial decision-making across the full business journey

Value communication to institutions and decision makers